Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study - Salomaa, V; Rasi, V; Pekkanen, J; Vahtera, E; Jauhiainen, M; Vartiainen, E; Ehnholm, C; Tuomilehto, J; Myllyla, G (Arterioscler Thromb Vasc Biol, 1995)